BMJ:有力证据!高水平维生素D或能降低患癌风险

2018-06-19 风铃 生物探索

不久前,发表在BMJ上的一篇论文证实,一项针对日本成年人的大型研究发现,高水平的维生素D可能与患癌(包括肝癌)风险降低有关。本周,又有新成果证明了血液中的维生素D水平与患癌风险之间的关联!

6月14日,发表在Journal of the National Cancer Institute杂志上题为"Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts"的研究中,来自美国癌症协会、哈佛大学陈曾熙公共卫生学院等机构的科学家们发现,较高的循环维生素D浓度与结直肠癌风险降低显着相关。

维生素D可由皮肤被阳光照射产生,有助于维持体内的钙水平,从而使骨骼、牙齿和肌肉保持健康。近年来,越来越多的证据表明,维生素D可能对其他慢性疾病(包括某些癌症)有好处。

先前,科学家们提出的假设是,维生素D可通过多种与细胞生长和调节相关的通路降低患结直肠癌的风险。不过,对于高浓度的循环25-羟基维生素D(25-hydroxyvitamin D)是否与患结直肠癌的风险降低有关,之前的前瞻性研究得出的结果是不一致的。此外,迄今完成的少数几个关于维生素D补充剂和结直肠癌的随机临床试验也尚未证明两者之间的关联。



Credit: CC0 Public Domain

为了解决先前研究的"不一致性",新研究中,科学家们利用标准化的条件(standardized criteria)分析了来自17个前瞻性队列研究的参与者的维生素D水平数据(participant-level data,收集于被诊断为结直肠癌之前)。分析共涉及了来自美国、欧洲和亚洲的5700多例结直肠癌病例以及7100名对照。

结果显示,随访期间(平均为5.5年),与那些循环维生素D浓度足以保证骨骼健康的参与者相比,维生素D浓度不足的参与者患结直肠癌的风险增加了31%。而循环维生素D浓度高于骨骼健康所需浓度则与"患结直肠癌的风险降低22%"有关。即使在调整了已知的结直肠癌风险因素后,这些关联仍然存在。

论文共同第一作者Marji L. McCullough说:"目前,卫生机构并不推荐用维生素D预防结直肠癌,但这项研究增加了一些可供这些机构使用的新信息。此外,研究表明,推荐用于保证骨骼健康的维生素D浓度可能低于用于结直肠癌预防的最佳浓度。"

维生素D可从饮食中获得,也可从补充剂中获得,还可以通过"晒太阳"获得。不过,专家建议,尽可能通过饮食来获得维生素D,因为过度的紫外线辐射是皮肤癌的主要危险因素。

原始出处:

Marjorie L McCullough, et al. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts. JNCI: Journal of the National Cancer Institute, djy087, https://doi.org/10.1093/jnci/djy087.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061755, encodeId=83132061e554d, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri May 24 02:08:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848539, encodeId=4d3718485398e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sun Jan 06 14:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413466, encodeId=710a141346674, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601441, encodeId=723916014415b, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2019-05-24 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061755, encodeId=83132061e554d, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri May 24 02:08:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848539, encodeId=4d3718485398e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sun Jan 06 14:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413466, encodeId=710a141346674, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601441, encodeId=723916014415b, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2019-01-06 gaoxiaoe
  3. [GetPortalCommentsPageByObjectIdResponse(id=2061755, encodeId=83132061e554d, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri May 24 02:08:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848539, encodeId=4d3718485398e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sun Jan 06 14:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413466, encodeId=710a141346674, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601441, encodeId=723916014415b, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061755, encodeId=83132061e554d, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri May 24 02:08:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848539, encodeId=4d3718485398e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sun Jan 06 14:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413466, encodeId=710a141346674, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601441, encodeId=723916014415b, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Thu Jun 21 01:08:00 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2018-06-21 lq0307

相关资讯

Cell:研究发现能治疗糖尿病的潜在新疗法

发表在最新一期美国《细胞》杂志上的研究显示,激活维生素D受体有助于修复受损的胰岛贝塔细胞,有望成为治疗糖尿病的新疗法。

2018 意大利共识:儿童时期维生素D补充

维生素D在钙磷代谢调节中起了重要的作用,尤其是在儿童时期。维生素D缺乏不仅影响骨骼肌肉健康也可能引起各种急慢性疾病,本文主要针对婴幼儿以及青少年的维生素D补充提供指导建议。

JAMA Pediatr:别补了!婴儿补充维生素D没什么好处!

维生素D是人体必不可少的维生素,它能帮助机体吸收钙元素,促进骨骼的生长发育和牙齿的生长。根据2016年的一项研究,维生素D的合成首先是通过皮肤暴露在阳光下是自然产生的,但在欧洲,多达40%的欧洲人没有得到足够的阳光。

Lancet diabetes endo:备孕期间补充维生素D,可增加受孕、改善妊娠结局!

妊娠期维生素D缺乏与不良妊娠结局相关,但孕前维生素D浓度与活产间的关系尚不明确。Sunni L Mumford等人对孕前维生素D浓度和妊娠结局之间的关联进行评估。研究人员对分组随机、双盲、安慰剂对照的EAGeR试验的前瞻性队列进行二次分析。本研究人群为2007年6月15日-2011年7月15日间在美国4个临床中心招募的18-40岁的有1-2次流产史的女性。在尝试怀孕期间随访长达6个月经周期,若妊娠

JAMA:正常人补钙或维生素D不能预防骨折,反而增加肾结石风险

近期,美国预防服务工作组(USPSTF)在JAMA发表文章指出对于没有维生素D缺乏症、骨质疏松症或骨折史的人来讲,补钙或者补充维生素D均不能预防骨折,反而会增加肾结石风险。

J Bone Miner Res:钙和维生素D补充是否影响缺血性心脏事件或死亡风险?

2018年5月,英国和法国科学家在《J Bone Miner Res》发表了英国生物银行队列结果,表明钙和维生素D补充与缺血性心脏事件或死亡风险不相关。